Related Experiment Video
Updated: Feb 20, 2026
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.8K
Stage effect of chronic kidney disease in erectile function
Márcio Rodrigues Costa1, Viviane Campos Ponciano2, Théo Rodrigues Costa3
1Escola Médica da Universidade Federal de Goiás, GO Brasil.
Summary
Chronic kidney disease progression worsens erectile dysfunction. Lower glomerular filtration rates and advanced disease stages correlate with a higher prevalence and severity of erectile dysfunction in men undergoing conservative treatment.
Area of Science:
- Nephrology
- Urology
- Men's Health
Background:
- Erectile dysfunction (ED) is a common comorbidity in men with chronic kidney disease (CKD).
- The impact of CKD stage and glomerular filtration rate (GFR) on ED prevalence and severity requires further elucidation.
Purpose of the Study:
- To assess the influence of CKD stage and GFR on the prevalence and degree of ED.
- To investigate the relationship between CKD progression and erectile function.
Main Methods:
- A transversal study included 245 male patients with CKD (stages III-V) on conservative treatment.
- Erectile dysfunction was assessed using the International Index of Erectile Function (IIEF).
- Statistical analyses included Chi-square tests and Pearson correlation coefficients to compare groups and assess relationships.
Main Results:
- The prevalence of ED was higher in patients with CKD stages IV/V compared to stage III.
- A positive correlation was observed between GFR and IIEF scores, indicating better erectile function with higher GFR.
- CKD progression was associated with increased ED prevalence and severity.
Conclusions:
- CKD progression, characterized by decreased GFR and advanced disease stages, negatively impacts erectile function.
- Anticipating ED diagnosis and treatment may be possible by monitoring CKD progression.
More Related Videos
Related Concept Videos
01:25Chronic Kidney Disease I: Introduction
808
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
808
01:17Factors Affecting Renal Clearance: Renal Impairment
509
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
509
01:28Chronic Kidney Disease III: Interprofessional Care
495
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
495
01:24Chronic Kidney Disease II: Clinical Manifestations
730
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
730
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
291
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
291
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
265
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
265